These Biopharma Names Don’t Have the Flash of SpaceX, but They’re Reliable
Here are four biotech plays that should stand up if the market starts to break down.
Spotlight Shines on a SuRo Capital Position…And It’s Not the One You Think
It’s not OpenAI, nor is it affiliated with Nvidia.
May CPI, End to Ceasefire?: 8 Key Items Shaping the Stock Market Wednesday
TSM’s May revenue, SpaceX’s oversubscription, bank stress tests, and other headlines are moving stocks this morning.
OpenAI Files for IPO: 8 Key Items Shaping the Stock Market Tuesday
Israel-Iran tensions mount, NFIB warns of inflation and and other headlines are moving stocks this morning.
Think Friday Was Bad? Get Used to It
Let’s unpack what happened and why I expect more such days over the coming months.
Apple Set to Reboot AI Effort in CEO’s Final Stand: 8 Key Items Shaping the Stock Market Monday
Google & SpaceX, Nvidia & SK Hynix, Marvell joining the S&P 500, other headlines are moving stocks this morning.
While Everyone Was Selling, I Initiated a New Position in This Mid-Cap Biotech
I made exactly one trade Friday — and I went to Denmark to do it.
Private Credit Contagion Will Spread as Market Ventures into Uncharted Territory
When else in history have equities traded at record highs while consumer sentiment readings were at record lows?
New Morgan Stanley Price Target After Anthropic IPO Update
We will continue tracking IPO and M&A activity for signs of even further upside.
Market Shifts Into Full Mania Mode
As AI trade continues to enter more and more radical territory, I’m bracing for a bad ending.